Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Colistimethate Sodium (2Million IU)
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
W.F.I. + Tray
Packaging
Vial
Price
₹2615/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Clickstin 2MIU Injection contains Colistimethate Sodium (2 Million IU), an advanced antibiotic designed for the treatment of severe infections caused by multidrug-resistant Gram-negative bacteria. It is primarily used in critically ill patients to manage infections such as pneumonia, bloodstream infections, urinary tract infections, and intra-abdominal infections caused by pathogens like Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii. Colistimethate works by disrupting bacterial cell membranes, effectively halting bacterial growth and preventing further spread.
This injection is reserved for hospital use and is administered under strict medical supervision. It is particularly beneficial in cases where other antibiotics have failed or resistance has developed, ensuring targeted therapy for life-threatening conditions.
Side effects may include kidney function impairment, neurotoxicity (tingling or dizziness), or rare allergic reactions.
Treats severe infections caused by multidrug-resistant Gram-negative bacteria, particularly in hospitalized or critically ill patients.
Administer only under medical supervision. Dosage should be carefully adjusted for patients with kidney impairment.
Store at 2°C to 8°C in a refrigerator. Protect from light. Reconstituted solution should be used immediately unless instructed otherwise by a healthcare professional.
Composition : Colistimethate Sodium (1Million IU)
Composition : Clarithromycin (500mg) Injection
Composition : Cefepime (1000mg) + Tazobactum (125mg)
Composition : Cefoperazone (1000mg) + Sulbactam (500mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (1000mg) + Sulbactam (500mg)
Composition : Ceftazidime (250mg) + Sulbactam (125mg)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Colistimethate Sodium 2 Million IU Injection has strong demand in the ICU and critical care antibiotic segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from its use in severe multidrug-resistant (MDR) gram-negative infections, hospital-acquired infections, and life-threatening ICU cases. It strengthens their critical care injectable portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Colistimethate Sodium 2 Million IU Injection with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong hospital and ICU demand, high-value prescriptions, better margins, and consistent institutional supply opportunities when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this critical care antibiotic can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.